Bionano Genomics (BNGO) Change in Account Payables (2017 - 2026)
Bionano Genomics (BNGO) posted Change in Account Payables of -$528000.0 for Q1 2026, down 32.33% sequentially from -$399000.0 in Q4 2025, and down 31.67% YoY from -$772729.9 in Q1 2025.
Bionano Genomics (BNGO) Change in Account Payables (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Change in Account Payables for 10 years, with the latest figure at -$528000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 31.67% year-over-year to -$528000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 54.35% YoY) and the FY2025 annual result came in at -$1.4 million, up 59.88% from the prior year.
- Change in Account Payables declined to -$528000.0 in Q1 2026 per BNGO's latest filing, from -$399000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.2 million in Q3 2023 and troughed at -$4.4 million in Q4 2023.
- A 5-year average of -$315647.1 and a median of -$399000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables jumped 280.0% in 2023, then tumbled 719.35% in 2025.
- Over 5 years, Change in Account Payables stood at $3.2 million in 2022, then sank by 238.15% to -$4.4 million in 2023, then soared by 60.4% to -$1.7 million in 2024, then jumped by 77.08% to -$399000.0 in 2025, then slumped by 32.33% to -$528000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$528000.0, -$399000.0, and -$254000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | -500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -500,000.00 |
| Jun 30, 2026 | -500,000.00 |
| Mar 31, 2026 | -528,000.00 |
| Mar 31, 2026 | -528,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | -401,000.00 |
| Mar 31, 2025 | -401,000.00 |
| Dec 31, 2024 | -1.74 Mn |
| Dec 31, 2024 | -1.74 Mn |
| Sep 30, 2024 | -31,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | -537,000.00 |
| Mar 31, 2024 | -537,000.00 |